Musa Jalloh – Trademark Portfolio
Entity Type: 01
Musa Jalloh holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include JAMTAN and ANGRY ELEPHANT BY BRAVO. The owner is based in Bronx, NY.
1479 Westchester Ave
Bronx, NY 10472
Showing of trademarks Trademarks
Trademark Classifications
Musa Jalloh's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Advertising; business management; business administration; office functions
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Musa Jalloh have?
Musa Jalloh has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does Musa Jalloh file in?
Musa Jalloh files trademarks across 4 Nice Classification classes. The most active classes are Class 30 (Staple Foods), Class 35 (Advertising & Business), Class 29 (Meats & Processed Foods), Class 31 (Natural Agricultural Products). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.
What are Musa Jalloh's most well-known trademarks?
Musa Jalloh's registered trademark portfolio includes well-known marks such as JAMTAN and ANGRY ELEPHANT BY BRAVO. These are among 2 currently registered trademarks in the portfolio.
What is Musa Jalloh's trademark registration success rate?
Musa Jalloh has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.